Literature DB >> 24680072

Identification of autoclave-resistant Anisakis simplex allergens.

Noelia Carballeda-Sangiao1, Fabiola Olivares2, Ana I Rodriguez-Mahillo1, Mercedes Careche2, Margarita Tejada2, Ignacio Moneo3, Miguel González-Muñoz4.   

Abstract

Anisakis simplex is a fish parasite able to induce allergic reactions in humans infected when eating raw or undercooked fish parasitized with viable third-stage larvae. Some authors claim that exposure to nonviable Anisakis material can result in allergic symptoms in previously sensitized patients, indicating that parasite allergens are resistant to the thermal treatments of usual cooking procedures. Furthermore, some patients report symptoms after eating canned fish. The aim of this work was the analysis of parasite allergen stability in heating to 121 °C in an autoclave to simulate the thermal process applied to canned fish. Third-stage larvae were subjected to autoclaving for 20, 40, and 80 min, and parasite crude extracts were analyzed by electrophoresis, immunoblotting, and a flow-cytometric basophil activation test. Allergens resistant to autoclaving were separated by reversed-phase high-performance liquid chromatography and identified by ion trap mass spectrometry. Protein analysis by sodium dodecyl sulfate-polyacrylamide gel electrophoresis showed that autoclaving considerably reduced the number and intensity of identifiable protein bands in a time-dependent manner. Several allergens were detected by immunoblotting with a pool of A. simplex allergic patients' sera after autoclaving. Allergens of 9 and 14 kDa resistant to autoclaving were identified as Ani s 4 and Ani s 1 allergens, respectively. Functional analysis showed that allergens retain their capacity to activate basophils even after autoclaving for 80 min. In conclusion, some relevant A. simplex allergens retain their capacity to bind immunoglobulin E and activate basophils after being subjected to autoclaving, which is a method equivalent to that used in industrial canning processes.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24680072     DOI: 10.4315/0362-028X.JFP-13-278

Source DB:  PubMed          Journal:  J Food Prot        ISSN: 0362-028X            Impact factor:   2.077


  7 in total

1.  Exposure to Anisakis extracts can induce inflammation on in vitro cultured human colonic cells.

Authors:  Antonio Speciale; Domenico Trombetta; Antonella Saija; Antonio Panebianco; Filippo Giarratana; Graziella Ziino; Paola Lucia Minciullo; Francesco Cimino; Sebastiano Gangemi
Journal:  Parasitol Res       Date:  2017-07-12       Impact factor: 2.289

Review 2.  New Perspectives on the Diagnosis of Allergy to Anisakis spp.

Authors:  Ignacio Moneo; Noelia Carballeda-Sangiao; Miguel González-Muñoz
Journal:  Curr Allergy Asthma Rep       Date:  2017-05       Impact factor: 4.806

Review 3.  Allergic reactions to Anisakis found in fish.

Authors:  Natalie E Nieuwenhuizen; Andreas L Lopata
Journal:  Curr Allergy Asthma Rep       Date:  2014-08       Impact factor: 4.806

Review 4.  Excretory/secretory products of anisakid nematodes: biological and pathological roles.

Authors:  Foojan Mehrdana; Kurt Buchmann
Journal:  Acta Vet Scand       Date:  2017-06-23       Impact factor: 1.695

5.  Proteomic and Bioinformatic Investigations of Heat-Treated Anisakis simplex Third-Stage Larvae.

Authors:  Maciej Kochanowski; Mirosław Różycki; Joanna Dąbrowska; Aneta Bełcik; Jacek Karamon; Jacek Sroka; Tomasz Cencek
Journal:  Biomolecules       Date:  2020-07-16

6.  Proteomic Profiling and In Silico Characterization of the Secretome of Anisakis simplex Sensu Stricto L3 Larvae.

Authors:  Maciej Kochanowski; Joanna Dąbrowska; Mirosław Różycki; Jacek Sroka; Jacek Karamon; Aneta Bełcik; Weronika Korpysa-Dzirba; Tomasz Cencek
Journal:  Pathogens       Date:  2022-02-14

Review 7.  Advances in Omic Studies Drive Discoveries in the Biology of Anisakid Nematodes.

Authors:  Stefano D'Amelio; Fabrizio Lombardo; Antonella Pizzarelli; Ilaria Bellini; Serena Cavallero
Journal:  Genes (Basel)       Date:  2020-07-15       Impact factor: 4.096

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.